|
市場調査レポート
商品コード
1518350
がん情報システム市場:オファリング、用途、エンドユーザー別-2030年までの世界予測Oncology Information Systems Market By Offering (Software Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) - Global Forecast to 2030 |
||||||
カスタマイズ可能
|
がん情報システム市場:オファリング、用途、エンドユーザー別-2030年までの世界予測 |
出版日: 2024年06月01日
発行: Meticulous Research
ページ情報: 英文 180 Pages
納期: 5~7営業日
|
がん情報システム市場は、2023~2030年のCAGRが7.4%で、2030年には44億5,000万米ドルに達すると予測されます。
本レポートでは、広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、主要な業界促進要因、抑制要因、市場促進要因・課題の分析を提供しています。
この市場の成長は、がんの有病率の増加、がん治療におけるデジタル化の進展、がん治療費の削減ニーズの高まり、電子カルテ(EHR)の採用の増加、合理化された患者情報とデータ管理に対する需要の高まりが原動力となっています。
しかし、がん情報システムの高コストやデータのセキュリティとプライバシーに関する懸念が、この市場の成長を抑制しています。さらに、がん治療への精密医療の統合と新興国におけるその可能性の高まりは、この市場の参入企業に大きな成長機会をもたらすと期待されています。
しかし、がん情報システムの導入と実装に対する障壁と、がん情報システムを使用するためのトレーニングと教育に対する追加要件は、市場の成長を制限する主要課題です。
(注:主要企業5社のSWOT分析が報告書に掲載されます。)
Oncology Information Systems Market Size, Share, Forecast, & Trends Analysis by Offering (Software {Patient Information, Treatment Planning}, Services), Application (Surgical, Radiology Oncology), End User (Hospital, Cancer Care) - Global Forecast to 2030
The oncology information systems market is projected to reach $4.45 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, the growing need to reduce oncology care costs, the increasing adoption of Electronic Health Records (EHR), and the growing demand for streamlined patient information and data management.
However, the high cost of oncology information systems and data security and privacy concerns are restraining the growth of this market. In addition, the integration of precision medicine into cancer treatment and its growing potential in emerging countries are expected to generate significant growth opportunities for the players in this market.
However, barriers to the adoption and implementation of oncology information systems and additional requirements for training and education for using oncology information systems are major challenges limiting the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).
Based on offering the oncology information systems market is segmented into software and services. In 2023, the software segment is expected to account for the larger share of the oncology information systems market. The large share of this segment is attributed to the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.
Based on application, the oncology information systems market is segmented into medical oncology, radiation oncology, and surgical oncology. In 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.
Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement oncology information systems, and increased number of cancer patients relying on hospitals for treatment.
An in-depth analysis of the geographical scenario in the oncology information systems market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the oncology information systems market. North America's major market share is primarily attributed to the robust healthcare infrastructure, high healthcare expenditure, large patient population, high adoption of precision medicine, and the presence of key market players in the region.
Oncology Information Systems Market Assessment-by Offering
Oncology Information Systems Market Assessment-by Application
Oncology Information Systems Market Assessment-by End User
Note: Other end users primarily include research institutes and government institutions.
Oncology Information Systems Market Assessment-by Geography
(Note: SWOT Analysis Of The Top 5 Players Will Be Provided In The Report)